Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The Sikiric group has consistently characterized BPC-157 as resistant to degradation in human gastric juice, a property attributed to its compact 15-residue length, its five proline residues (which disrupt protease recognition motifs), and the absence of cysteine-bridgedependent tertiary structure (Sikiric et al., 2018)
Research protocols typically use 0.25-0.5 mg daily via subcutaneous injection near the wrist for 4-8 weeks
A clear solution indicates complete dissolution
Not intended for injection, ingestion, or topical use
US$ 27.85
US$ 25.71
US$ 22.59
US$ 24.80
